MARKET

AZTA

AZTA

Azenta Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

75.12
+3.52
+4.92%
Closed 16:15 05/13 EDT
OPEN
72.78
PREV CLOSE
71.60
HIGH
76.46
LOW
72.78
VOLUME
781.34K
TURNOVER
--
52 WEEK HIGH
124.79
52 WEEK LOW
61.35
MARKET CAP
5.63B
P/E (TTM)
-102.4829
1D
5D
1M
3M
1Y
5Y
--KeyBanc Lowers Azenta's Price Target to $90 From $132, Maintains Overweight Rating
MT Newswires · 6d ago
--Needham Adjusts Azenta's Price Target to $94 From $115, Citing Peer Multiple Contraction, Reiterates Buy Rating
MT Newswires · 6d ago
BRIEF-Azenta Q2 Revenue Rose 12 Percent To $146 Million
reuters.com · 6d ago
Azenta Non-GAAP EPS of $0.12 beats by $0.01, revenue of $146M beats by $3.9M
Azenta press release (NASDAQ:AZTA): Q2 Non-GAAP EPS of $0.12 beats by $0.01. Revenue of $146M (+12.3% Y/Y) beats by $3.9M. For Q3, revenue is expected to be in the range
Seekingalpha · 6d ago
-- Earnings Flash (AZTA) AZENTA Posts Q2 Revenue $145.5M, vs. Street Est of $142.1M
MT Newswires · 6d ago
-- Earnings Flash (AZTA) AZENTA Posts Q2 EPS $0.12, vs. Street Est of $0.11
MT Newswires · 6d ago
Earnings Scheduled For May 9, 2022
  Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.
Benzinga · 05/09 08:52
Notable earnings after Monday's close
ADES, AGM, AIV, AKBA, ALCO, ALTO, AMC, AMPH, AMWL, ANGI, APPF, APTO, ARCT, AROC, ASLE, ASRT, ATER, AVIR, AZTA, BATL, BHF, BLFS, BLI, BLNK, BODY, OTCPK:BOWFF, BRMK, BRT, BW, BWXT,
Seekingalpha · 05/08 21:35
More
No Data
Learn about the latest financial forecast of AZTA. Analyze the recent business situations of Azenta Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

33.33%Strong Buy
66.67%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average AZTA stock price target is 100.57 with a high estimate of 121.00 and a low estimate of 85.00.
High121.00
Average100.57
Low85.00
Current 75.12
EPS
Actual
Estimate
0.200.390.590.78
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Institutional Holdings
Institutions: 514
Institutional Holdings: 81.59M
% Owned: 108.91%
Shares Outstanding: 74.92M
TypeInstitutionsShares
Increased
123
1.99M
New
63
5.32M
Decreased
159
5.28M
Sold Out
47
984.33K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+4.51%
Pharmaceuticals & Medical Research
+1.39%
Key Executives
Non-Executive Chairman/Independent Director
Joseph Martin
President/Chief Executive Officer/Director
Stephen Schwartz
Chief Financial Officer/Executive Vice President
Lindon Robertson
Chief Operating Officer
Matthew McManus
Chief Human Resource Officer/Senior Vice President
Kimberly Crowley
Senior Vice President/General Counsel/Secretary
Jason Joseph
Senior Vice President/General Manager
Robin Vacha
Senior Vice President/Director of Human Resources
William Montone
Senior Vice President
Linda De Jesus
Senior Vice President
David Gray
Chief Accounting Officer/Vice President - Finance/Controller
Vandana Sriram
Independent Director
Frank Casal
Independent Director
Robyn Davis
Independent Director
Erica Mclaughlin
Independent Director
Krishna Palepu
Independent Director
Michael Rosenblatt
Independent Director
Alfred Woollacott
Independent Director
Mark Wrighton
Independent Director
Ellen Zane
No Data
No Data
About AZTA
Azenta, Inc. (Azenta), formerly Brooks Automation, Inc., is a provider of life sciences solutions worldwide, enabling therapies to market faster. Azenta provides a full suite of cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for pharmaceutical, biotech, academic and healthcare institutions globally. The Company's services include genomics services, sample and management solutions, sample and material storage, clinical trial management, drug products and cell therapies, sample prep and lab services, lab moving and biological transport, information technology solutions, and business continuity and risk mitigation. Azenta has operations in North America, Europe and Asia.

Webull offers kinds of Azenta Inc stock information, including NASDAQ:AZTA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AZTA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading AZTA stock methods without spending real money on the virtual paper trading platform.